SCHEMBL25194892

SCHEMBL25194892

CC(C)(C)c1ccc(Nc2ccc(/C=N\O)cc2)cc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.44
▸ ACHE P22303 1/20 0.36
▸ CFTR P13569 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ PTGS1 P23219 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ GAA P10253 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ S100B P04271 1/20 0.33
▸ MAPT P10636 2/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ MITF O75030 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ SOS1 Q07889 1/20 0.31
▸ DHODH Q02127 1/20 0.31
▸ PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25187893 0.81 KIF11 (0.46) CFTRALDH1A1PTGS1PTGS2GAA
SCHEMBL26154817 0.77 MAPT (0.50) HTTKMT2AMEN1GAAMAPT
SCHEMBL25190810 0.73 ALDH1A1 (0.43) HTTACHEALOX12KMT2AALDH1A1
SCHEMBL25204894 0.72 CFTR (0.36) CFTRGAAMAPTHPGDSOS1
SCHEMBL5422583 0.69 S100B (0.59) HTTALOX12KMT2AALDH1A1MEN1
SCHEMBL13528298 0.69 CFTR (0.40) HTTCFTRKMT2AMEN1MAPT
SCHEMBL5422579 0.69 S100B (0.59) HTTALOX12KMT2AALDH1A1MEN1
SCHEMBL25190165 0.69 RIPK1 (0.44) CFTR
SCHEMBL22399115 0.68 L3MBTL1 (0.58) CFTRALOX12KMT2AALDH1A1MEN1
SCHEMBL16962162 0.68 PTGS1 (0.43) HTTCFTRALDH1A1PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151252-B Iron death inhibitor-diarylamine acetamides 维泰瑞隆有限公司 2024-08-27 — — CN disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
CN-115151252-A Iron death inhibitors diarylamine para-acetamides 维泰瑞隆有限公司 2022-10-04 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES AIFM2, FECH, GPX4 HTT 2801/4885ACHE 3562/4885CFTR 2526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback